| Sample | Title | Value | Rank |
|---|
| GSM780707 | Untreated after 4 days (C1_1) | 1916.18 | 98 |
| GSM780708 | Untreated after 4 days (C2_1) | 1382.89 | 97 |
| GSM780709 | Untreated after 4 days (C3_1) | 1223.83 | 96 |
| GSM780719 | Untreated after 4 days (C1_2) | 1896.14 | 98 |
| GSM780720 | Untreated after 4 days (C2_2) | 1374.38 | 97 |
| GSM780721 | Untreated after 4 days (C3_2) | 1147.34 | 96 |
| GSM780710 | Trastuzumab treated after 4 days (T1_1) | 1246.13 | 96 |
| GSM780711 | Trastuzumab treated after 4 days (T2_1) | 1680.33 | 97 |
| GSM780712 | Trastuzumab treated after 4 days (T3_1) | 1610.16 | 97 |
| GSM780722 | Trastuzumab treated after 4 days (T1_2) | 1222.49 | 96 |
| GSM780723 | Trastuzumab treated after 4 days (T2_2) | 1788.16 | 98 |
| GSM780724 | Trastuzumab treated after 4 days (T3_2) | 1655.52 | 97 |
| GSM780713 | Pertuzumab treated after 4 days (P1_1) | 1776.96 | 98 |
| GSM780714 | Pertuzumab treated after 4 days (P2_1) | 1490.19 | 97 |
| GSM780715 | Pertuzumab treated after 4 days (P3_1) | 1705.58 | 97 |
| GSM780725 | Pertuzumab treated after 4 days (P1_2) | 1858.14 | 98 |
| GSM780726 | Pertuzumab treated after 4 days (P2_2) | 1587.83 | 97 |
| GSM780727 | Pertuzumab treated after 4 days (P3_2) | 1758.72 | 98 |
| GSM780716 | Trastuzumab and Pertuzumab treated after 4 days (TP1_1) | 1410.95 | 97 |
| GSM780717 | Trastuzumab and Pertuzumab treated after 4 days (TP2_1) | 1498.31 | 97 |
| GSM780718 | Trastuzumab and Pertuzumab treated after 4 days (TP3_1) | 1447.03 | 97 |
| GSM780728 | Trastuzumab and Pertuzumab treated after 4 days (TP1_2) | 1468.94 | 97 |
| GSM780729 | Trastuzumab and Pertuzumab treated after 4 days (TP2_2) | 1419.94 | 97 |